PTT-LA (Lupus Anticoagulant Sensitive PTT)

PTT-LA is a clotting test that measures how long your plasma takes to form a clot using a reagent designed to be especially sensitive to lupus anticoagulant antibodies. It is a modified version of the activated partial thromboplastin time that uses low phospholipid content so that lupus anticoagulants, if present, are more likely to prolong the clotting time.

This test is used as part of an evaluation for antiphospholipid antibodies. It is a screening step and is usually interpreted alongside other tests, such as the dilute Russell viper venom time and confirmatory assays that add excess phospholipid to check for correction.

Lupus anticoagulants are autoantibodies that can interfere with phospholipid-dependent clotting tests in the laboratory, often making results look prolonged. In the body, however, their presence is linked to a higher risk of blood clots and pregnancy complications. Identifying these antibodies helps your care team assess your risk and plan monitoring or treatment when appropriate.

Your clinician may order PTT-LA if you have a history of clots, certain pregnancy losses, an unexplained prolonged aPTT result, or signs of autoimmune disease. The result guides whether more specific tests are needed and can influence decisions about anticoagulation, surgery planning, and pregnancy care.

A result within the laboratory’s expected range makes a strong lupus anticoagulant less likely, but it does not completely rule it out. A prolonged result suggests the possibility of a lupus anticoagulant or, less commonly, a clotting factor deficiency or another inhibitor.

To clarify the cause, the laboratory may perform a mixing study, heparin neutralization, and a confirmatory test that adds excess phospholipid to see whether the clotting time shortens. Results are interpreted together with other antiphospholipid antibody tests. Be sure to tell your care team about all medicines and supplements, especially blood thinners, since some can affect this assay and lead to misleading results.

If your result is abnormal, your clinician will discuss next steps, which may include repeat testing, additional antibody testing, or timing the test when you are not taking certain medications. Decisions about treatment are based on your overall history and risk, not on a single test.